GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) » Definitions » Valuation Rank

Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) Valuation Rank


View and export this data going back to 2004. Start your Free Trial

What is Y.S.P. Southeast Asia Holding Bhd Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Y.S.P. Southeast Asia Holding Bhd Valuation Rank Related Terms

Thank you for viewing the detailed overview of Y.S.P. Southeast Asia Holding Bhd's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Y.S.P. Southeast Asia Holding Bhd Business Description

Traded in Other Exchanges
N/A
Address
Number 1, Jalan Wan Kadir, Level 22, Menara LGB, Taman Tun Dr. Ismail, Kuala Lumpur, MYS, 60000
Y.S.P. Southeast Asia Holding Bhd is an investment company, which engages in the pharmaceutical business, and provision of management services. It operates through the following segments: Trading, Manufacturing, and Investment Holding. The Trading segment imports, exports, and trades various kinds of pharmaceutical products, and traditional herbal and veterinary products. The Manufacturing segment manufactures pharmaceutical products. The Investment Holding segment focuses on investment holding activity. The firm's majority of revenue comes from the Manufacturing segment. The majority of revenue is concentrated in Malaysia.